Femal scientist analyzing chemicals
Femal scientist analyzing chemicals

Why Denmark is a top location in Europe for clinical trials

Why Denmark is a top location in Europe for clinical trials

Looking for the best place in Europe to conduct clinical trials? Choose Denmark. 

With world-class infrastructure, streamlined processes, and unmatched public-private collaboration, Denmark is increasingly the preferred destination for global pharmaceutical, biotech, and health technology companies conducting clinical research.

Denmark offers All the right conditions for clinical research

Denmark combines a strong healthcare system with an innovation-driven business environment.

A highly skilled workforce, advanced hospitals, strong research environments and supportive authorities make Denmark a standout destination for clinical trials in Europe. The Danish government actively strengthens the life sciences sector with policies that enhance the framework conditions for clinical research.

Denmark sets new 14 day benchmark for approval timelines 

Denmark has established a new EU benchmark for clinical trial timelines by implementing an accelerated approval process for Phase I trials. Under this new framework, applications for early-phase clinical studies are now reviewed and processed within just 14 days - a significant reduction compared to standard EU timelines.

This initiative positions Denmark at the forefront of clinical research efficiency, ensuring faster study initiation while maintaining the highest standards of safety and regulatory oversight. The shortened review period reflects Denmark’s commitment to fostering innovation, attracting global investments, and supporting the rapid translation of scientific discoveries into patient-ready therapies.

National entry point for companies 

Trial Nation makes it easy for global companies to conduct clinical trials in Denmark.

Established in 2018, Trial Nation acts as a single national entry point for companies looking to carry out trials in Denmark. Its services are free of charge and include:

  • Rapid investigator identification.
  • A coordinated feasibility process with a national response from hospital sites within five days.
  • Access to Trial Nations legal network offering legal advice and national contract negotiations.
  • Access to established clinical specialty centres and national networks within oncology, haematology, dermatology, paediatrics, respiratory diseases, infectious diseases and dementia.
  • And access to established partnerships with hospitals, scientists and patient networks 
  • Support for both pharmaceutical, biotech and health technology clinical trials.

Proactive approach towards Decentralised clinical trials 

Denmark is a global frontrunner in decentralised clinical trials (DCTs).

DCTs enable faster execution, greater diversity, and improved access for participants. Denmark’s leadership is driven by the proactive Danish Medicines Agency, which released its national DCT guideline in 2021. Collaboration between authorities, researchers, patients and industry is accelerating adoption. 

Top 10 Reason to conduct clinical trials in Denmark : 

take a deep dive

Download the Clinical Trials in Denmark Business Brief

Learn more about why your company should look to Denmark to conduct your clinical trials and read statements from companies already conducting clinical trials in Denmark.

Talk to our experts

Want to know more about clinical trials in Denmark?

Our dedicated life science investment advisors are ready to assist you with tailored insights, partner matching and next steps.

Copenhagen

  • Sarina Lohmann

    Title: Special Advisor – Maritime and transport – Analysis & Partnerships

    Area: Copenhagen

    Phone: +4533920423

Berlin

Kolding

Silkeborg

Aarhus

Aalborg

Oslo

London

Paris

Munich

New-York

Toronto

Silicon-Valley

Tokyo

Bangalore

Taipei

Shanghai

Singapore